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‘‘Could I be allergic to my new hidradenitis suppurativa Medication?’’ Characterization of a cutaneous delayed-type drug hypersensitivity reaction to secukinumab
Nayha Shetty, MD, Henry Ford Health System; Sasank Konda, MD, Henry Ford
Health System; Jesse Veenstra, MD, PhD, Henry Ford Health System
Patient history and physical: A 32-year-old Asian-American female presented with
widespread, pruritic, red papules involving the ears, trunk, and extremities for
approximately 6 weeks’ duration. The lesions first developed several days after her
second secukinumab injection, which was originally initiated for recalcitrant stage
III hidradenitis suppurativa. Physical examination revealed numerous erythematous,
scaly papules on the bilateral ears, upper chest, inframammary folds, bilateral upper
extremities, and abdomen (including umbilicus). Large, well-demarcated, moistappearing plaques were observed to involve the bilateral axillary folds symmetrically. Her vital signs were stable, and she denied recent facial swelling or urticaria.
Pathology: A punch biopsy obtained from the right flank revealed psoriasiform
epidermal hyperplasia with spongiosis, lymphocyte exocytosis, and serous crusting
with ample neutrophils in the stratum corneum. A dense superficial perivascular
and interstitial infiltrate of lymphocytes with numerous eosinophils was also
observed. Periodic acid-Schiff stain was negative for fungal elements.
Laboratory data: Bacterial swab revealed mixed skin flora.
Diagnosis: A diagnosis of a cutaneous delayed-type drug hypersensitivity reaction to
secukinumab was made. SDRIFE was also considered, however, our patient did not
exhibit gluteal, perineal, or inguinal involvement.
Clinical course and treatment: Secukinumab was discontinued, and because the
mean half-life ranges from 22 to 31 days, an 8-week prednisone taper was initiated
with resolution of the rash. Following completion of the original taper, the patient
experienced a mild recurrence of the original rash, which fully resolved without
recurrence after an additional 4 weeks of prednisone. Ustekinumab was subsequently initiated for control of underlying hidradenitis suppurativa.

32316
Five-year cancer-specific survival for melanoma in LEP: An
analysis of the SEER database
Devin K. Barzallo, BA, Case Western Reserve University School of
Medicine; Dustin DeMeo, BSE, Case Western Reserve University School
of Medicine; Bryan T. Carroll, MD, PhD, UH Cleveland Medical Center,
Department of Dermatology
Limited English Proficient (LEP) patients have been shown to have barriers to health
care access. LEP is concentrated amongst Asian and Hispanic White populations.
There is little known about cancer specific health outcomes for LEP melanoma
patients. We hypothesized that there would be a statistically greater 5-year Cancer
Specific Survival (CSS) in low LEP counties compared with high LEP counties. We
performed a retrospective cross-sectional study on Asian and Hispanic White
melanoma patients from the Surveillance, Epidemiology, and End Results database
(SEER, 2018, 18 Reg.). 5-year CSS was compared between low LEP (0-12% LEP
population) vs high LEP counties ($12% LEP population) using a Kaplan-Meier
analysis. A Cox proportional hazards regression was performed to investigate the
effects of age of diagnosis, and county LEP status on 5-year CSS. A total of 8490 adult
Asian and Hispanic White melanoma patients were identified, of whom 660 were in
high LEP counties (7.8%). Mean age of diagnosis in high LEP counties (60.3 6
17.7yo) was later than in low LEP counties (58.1 6 16.9 yo, P ¼ .002). 5-year
melanoma CSS was marginally lower among patients in high LEP counties (P \.15).
County LEP status did not confer a significant hazard (P ¼ .334). 5-year melanoma
CSS decreased with age of diagnosis (HR 1.01 per year, 95% CI [1.01-1.02]). Our
results indicate that once diagnosed LEP does not affect a patient’s 5 year Cancer
specific survival indicating the importance of melanoma screen in high LEP counties
for early detection of melanoma. A limitation to this study is that it uses county level
LEP data.
Commercial Disclosure: None identified.

Commercial Disclosure: None identified.
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‘‘Nothing really seemed to touch it that wasn’t a steroid’’: An
analysis of social media posts regarding the efficacy of topical
corticosteroid use in atopic dermatitis
Jeffrey R. Rajkumar, BS, University of Illinois at Chicago College of
Medicine; Yasmin Gutierrez, BS, University of California Riverside School of
Medicine; Madison E. Jones, BA, University of Southern California Keck School of
Medicine; Sarah P. Pourali, BS, Vanderbilt University School of Medicine; Alison
H. Kohn, BS, Florida Atlantic University Charles E. Schmidt College of Medicine;
April W. Armstrong, MD, MPH, University of Southern California Keck School of
Medicine
The objective of this study is to characterize the sentiment and engagement of online
posts regarding the efficacy of TCS use for atopic dermatitis. 2047 posts and
comments which referenced TCS use were extracted from publicly accessible
Facebook (FB) and Reddit eczema groups; 412 referenced TCS efficacy. These posts
were assigned a sentiment of positive, negative, or neutral; posts were also assigned
an engagement score calculated by adding likes, upvotes, and replies. Neutral
sentiment (n ¼ 270, 65.5%) was more common than negative (n ¼ 50; 12.1%) or
positive (n ¼ 92; 22.3%%) sentiment. Sentiments were assigned a value of -1
(negative), 0 (neutral), and 1 (positive). Mean sentiment score (MSS) was
significantly (P \.05) higher in FB (0.40, 95% CI [.17-.63]) compared with Reddit
(0.06, [.01-.12]). Mean engagement score (MES) was significantly (P \.05) higher in
Reddit (8.97, [6.45-11.49]) compared with FB (0.93, [.42-1.45]). Although concerns
from patients regarding the safety of TCS use have been well-documented1, social
media analysis of posts and comments shows a neutral or slightly positive attitude
towards their efficacy. Reddit as a social media platform is rapidly gaining
recognition in social science2 and medical3 research; the relatively higher
engagement and lower sentiment compared with FB found among Reddit posts
suggests that evidence-based online education efforts from dermatologic providers
on this particular social media platform may be useful to increase patient knowledge
and confidence in their therapies.
Commercial Disclosure: None.
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A 10% urea moisturizer improves the signs and symptoms of foot
xerosis in diabetic patients
Dillon Nussbaum, BSc, Department of Dermatology, George
Washington School of Medicine and Health Sciences; Adam
Friedman, MD, Department of Dermatology, George Washington School of
Medicine and Health Sciences; Nadege Lachman, PhD, Galderma Research &
Development., LLC; Matthew, H. Meckfessel, PhD,
Foot xerosis is a common condition among type 2 diabetics and improper
management can lead to painful cracks and fissures and possibly neuropathic ulcers
and infections. Regular use of moisturizers is recommended to help manage and
prevent xerosis from developing. Urea is a natural moisturizing factor due to its
highly hygroscopic nature and a keratolytic, making it an ideal moisturizer
ingredient. The efficacy and safety of a moisturizing lotion containing 10% urea
(CSL) was assessed in 20 subjects with type 2 diabetes. Subjects with moderate dry
feet, including fissuring, applied CSL daily to 1 randomly selected foot for 28 days.
The other foot served as an untreated, internalized control. Clinical assessments
included dryness, fissures, and calluses; instrumental assessments included hydration, transepidermal water loss (TEWL), skin pH, and roughness. After 28 days, 90%
of the treated feet had normal or mildly dry skin compared with 25% of the untreated
feet (P \.05). The number of fissures, calluses, skin hydration, and skin roughness
also significantly improved on the treated feet compared with baseline (P \.05); no
improvement was observed on the untreated foot. However, there was no
significant differences between TEWL and pH between the feet. No related adverse
events were reported. Overall, CSL was effective in improving xerotic feet in
diabetic patients.
Commercial Disclosure: Study funded by Galderma Research & Development,
LLC.
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